Business Context and Reporting Period
Company: Champions Oncology, Inc. (CSBR)
Filing Type: Form 8-K (Current Report)
Report Date: September 15, 2025
Reporting Period: First quarter ended July 31, 2025
Context: The filing serves to announce the issuance of a press release containing unaudited financial results for the quarter ended July 31, 2025. The press release is attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific financial data. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are located in the attached press release (Exhibit 99.1), which is not included in the input text. Therefore, the filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes versus the prior comparable period are detailed in the provided text. The document only confirms the release of results for the quarter ended July 31, 2025.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are expected to be found within the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific revenue, net loss, and cash position figures for the quarter ended July 31, 2025.
- Verify year-over-year comparisons and material changes in financial condition as detailed in the press release.
- Check for any updated operational milestones or clinical trial progress mentioned in the full press release.
- Confirm the company's liquidity status and runway based on the unaudited results.